In addition, many studies have demonstrated that the levels of CYR61 are upregulated in inflammatory diseases, such as Graves’ orbitopathy, rheumatoid arthritis, and pulmonary hypertension (23–25). This evidence concerns the gene CCN1 and pulmonary hypertension.